COVID-19 and diabetes management: What should be considered?

Diabetes Res Clin Pract. 2020 May:163:108151. doi: 10.1016/j.diabres.2020.108151. Epub 2020 Apr 17.
No abstract available

Keywords: COVID-19; Cardiovascular disease; DPP4; Diabetes; GLP-1RA; Hydroxychloroquine; Pioglitazone; SGLT-2.